- Home
- HUBCW vs CRNX Comparison
HUBCW vs CRNX Comparison
Compare HUBCW & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBCW
- CRNX
- Stock Information
- Founded
- HUBCW N/A
- CRNX 2008
- Country
- HUBCW Israel
- CRNX United States
- Employees
- HUBCW 322
- CRNX N/A
- Industry
- HUBCW
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- HUBCW
- CRNX Health Care
- Exchange
- HUBCW Nasdaq
- CRNX Nasdaq
- Market Cap
- HUBCW N/A
- CRNX 2.8B
- IPO Year
- HUBCW N/A
- CRNX 2018
- Fundamental
- Price
- HUBCW N/A
- CRNX $30.00
- Analyst Decision
- HUBCW
- CRNX Strong Buy
- Analyst Count
- HUBCW 0
- CRNX 10
- Target Price
- HUBCW N/A
- CRNX $75.00
- AVG Volume (30 Days)
- HUBCW N/A
- CRNX 646.9K
- Earning Date
- HUBCW N/A
- CRNX 08-07-2025
- Dividend Yield
- HUBCW N/A
- CRNX N/A
- EPS Growth
- HUBCW N/A
- CRNX N/A
- EPS
- HUBCW N/A
- CRNX N/A
- Revenue
- HUBCW N/A
- CRNX $760,000.00
- Revenue This Year
- HUBCW N/A
- CRNX $402.12
- Revenue Next Year
- HUBCW N/A
- CRNX $770.88
- P/E Ratio
- HUBCW N/A
- CRNX N/A
- Revenue Growth
- HUBCW N/A
- CRNX N/A
- 52 Week Low
- HUBCW N/A
- CRNX $24.10
- 52 Week High
- HUBCW N/A
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- HUBCW N/A
- CRNX 44.17
- Support Level
- HUBCW N/A
- CRNX $28.34
- Resistance Level
- HUBCW N/A
- CRNX $30.01
- Average True Range (ATR)
- HUBCW 0.00
- CRNX 1.07
- MACD
- HUBCW 0.00
- CRNX -0.17
- Stochastic Oscillator
- HUBCW 0.00
- CRNX 36.41
About HUBCW Hub Cyber Security Ltd. Warrant 2/27/28
Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.